BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28043662)

  • 41. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
    Maioli M; Toso A; Gallopin M; Leoncini M; Tedeschi D; Micheletti C; Bellandi F
    J Cardiovasc Med (Hagerstown); 2010 Jun; 11(6):444-9. PubMed ID: 20164783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention.
    Liu Y; Lin L; Li Y; Li H; Wu DX; Zhao JB; Lian D; Zhou Y; Liu Y; Ye P; Ran P; Duan C; Chen S; Chen P; Xian Y; Chen J; Tan N
    Medicine (Baltimore); 2015 Dec; 94(50):e2258. PubMed ID: 26683946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
    Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
    EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.
    Kurtul A; Yarlioglues M; Duran M; Murat SN
    Heart Lung Circ; 2016 Jul; 25(7):683-90. PubMed ID: 26935164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
    Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
    Yildiz I; Yildiz PO; Rencuzogullari I; Karabag Y; Cagdas M; Burak C; Gurevin MS
    Angiology; 2019 Aug; 70(7):627-632. PubMed ID: 30712366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
    Zhang MM; Lv QZ; Li XY
    Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Delta Neutrophil Index for the Prediction of Contrast-Induced Nephropathy in Patients With St-Elevation Myocardial Infarction Followed By Percutaneous Coronary Intervention.
    Kong T; Park YS; Lee HS; Kim S; Han S; Eun CH; Lee JW; You JS; Chung HS; Park I; Chung SP
    Shock; 2018 Mar; 49(3):317-325. PubMed ID: 28885386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Tziakas D; Chalikias G; Stakos D; Altun A; Sivri N; Yetkin E; Gur M; Stankovic G; Mehmedbegovic Z; Voudris V; Chatzikyriakou S; Garcia-Moll X; Serra A; Passadakis P; Thodis E; Vargemezis V; Kaski JC; Konstantinides S
    Am J Cardiol; 2014 May; 113(9):1487-93. PubMed ID: 24630389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.
    Tziakas D; Chalikias G; Stakos D; Apostolakis S; Adina T; Kikas P; Alexoudis A; Passadakis P; Thodis E; Vargemezis V; Konstantinides S
    Int J Cardiol; 2013 Feb; 163(1):46-55. PubMed ID: 21641061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk score for contrast induced nephropathy following percutaneous coronary intervention.
    Ghani AA; Tohamy KY
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):240-5. PubMed ID: 19237811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
    Güngör B; Karataş MB; İpek G; Özcan KS; Çanga Y; Onuk T; Keskin M; Hayıroğlu Mİ; Karadeniz FÖ; Sungur A; Öztürk R; Bolca O
    Ren Fail; 2016 Sep; 38(8):1167-73. PubMed ID: 27436614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system.
    Inohara T; Kohsaka S; Abe T; Miyata H; Numasawa Y; Ueda I; Nishi Y; Naito K; Shibata M; Hayashida K; Maekawa Y; Kawamura A; Sato Y; Fukuda K
    Am J Cardiol; 2015 Jun; 115(12):1636-42. PubMed ID: 25891989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
    Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of CHA
    Samir A; Gabra W; Alhossary H; Bakhoum S
    Egypt Heart J; 2023 Jun; 75(1):52. PubMed ID: 37358644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.